Advanced Circulatory is a pioneer in Intrathoracic Pressure Regulation (IPR), a non-invasive therapy that enhances circulation and protects vital organs during medical emergencies. This innovative approach has broad implications for various medical conditions. The company's therapy platform, delivered through impedance threshold devices known as ResQPOD® and ResQGARD®, regulates intrathoracic pressure to optimize blood flow, making it valuable for both cardiac arrest patients during CPR and spontaneously breathing patients with poor perfusion.
Founded in 1997 and based in the United States, Advanced Circulatory operates at the intersection of Hardware, Health Care, Manufacturing, and Medical Devices. While specific investment details are not available, the company is focused on ongoing research to evaluate the long-term benefits of its therapy. For potential investors in the healthcare and medical device sectors, Advanced Circulatory presents an opportunity to support a pioneering technology with the potential to revolutionize emergency care and critical medical interventions.
There is no investment information
We care about your data, and we'd love to use cookies make your experience better.